Jianjun Zhang

80PUBLICATIONS
501CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (80)

|Sep 18, 2026
CT-based deep foundation model for predicting immune checkpoint inhibitor-induced pneumonitis risk in lung cancer.

|Jul 27, 2026
The genomic landscape and treatment outcomes associated with CDKN2A/MTAP loss in patients with non-small cell lung cancer.

|Jul 08, 2026
Unbiased avidity-based isolation of antigen-specific T cells.

|Jun 13, 2026
Deciphering small sequence differences in T cell receptor-antigen pairing.

|May 18, 2026
Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco.

|Apr 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.

Pageof 14

Frequent Collaborators

40 joint publications

John Victor Heymach

29 joint publications

Jia Wu

29 joint publications

Don L Gibbons

29 joint publications

Jack Lee